RecruitingPhase 2NCT06244979

iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Radboud University Medical Center
Principal Investigator
Roger Brüggemann, PhD
Radboud University Medical Center
Intervention
Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B)(other)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06244979 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials